90770788 - PHAIM AIM ANTIGENIC IMMUNE MODULATION

Information

  • Trademark
  • 90770788
  • Serial Number
    90770788
  • Registration Number
    6842815
  • Filing Date
    June 12, 2021
    4 years ago
  • Registration Date
    September 13, 2022
    3 years ago
  • Transaction Date
    September 13, 2022
    3 years ago
  • Status Date
    September 13, 2022
    3 years ago
  • Published for Opposition Date
    June 28, 2022
    3 years ago
  • Location Date
    September 13, 2022
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    GOODMAN, WENDY BETH
  • Attorney Docket Number
    1975.40007
    Attorney Name
    Joseph L. Morales
    Law Office Assigned Location Code
    L90
  • Owners
Mark Drawing Code
4000
Mark Identification
PHAIM AIM ANTIGENIC IMMUNE MODULATION
Case File Statements
  • GS0051: Vaccines; Chemical preparations for the diagnosis of diabetes; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations; Chemical preparations for medical purposes
  • GS0351: Advertising services relating to pharmaceuticals for the treatment of diabetes; Advertising services relating to pharmaceuticals; Advertising, marketing and promotional services; Advertising; Compilation of statistical data for use in scientific research; Compilation of statistical data relating to medical research; Advertising services to promote public awareness of medical conditions; Advertising services related to immune disorders; Advertising services related to autoimmune diseases
  • GS0441: Diabetes screening services; Medical services in the field of diabetes; Providing information via the Internet in the field of diabetes; Medical screening; Health screening services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services for the diagnosis of conditions of the human body; Medical services; Medical diagnostic services; Medical services for the treatment of conditions of the human body; Medical testing services relating to the diagnosis and treatment of disease; Performing diagnosis of diseases; Medical information services provided via the Internet; Providing medical information; Medical analysis services for autoimmune disease diagnosis and prognosis
  • GS0101: Medical test kits for diabetes monitoring for home use; Testing instruments for medical diagnostic purposes; Blood glucose testing apparatus; Apparatus for carrying-out diagnostic tests for medical purposes; Diagnostic, examination, and monitoring equipment; Medical apparatus for testing the level of glucose in the blood; Medical apparatus and instruments; Medical diagnostic instruments; Medical testing instruments
  • D10000: "ANTIGENIC IMMUNE MODULATION"
Case File Event Statements
  • 9/13/2022 - 3 years ago
    20 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 9/13/2022 - 3 years ago
    19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/28/2022 - 3 years ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/28/2022 - 3 years ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/8/2022 - 3 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/21/2022 - 3 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/15/2022 - 3 years ago
    14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/15/2022 - 3 years ago
    13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/15/2022 - 3 years ago
    12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/15/2022 - 3 years ago
    11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/11/2022 - 3 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/11/2022 - 3 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/9/2022 - 3 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 3/7/2022 - 3 years ago
    7 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 3/3/2022 - 3 years ago
    6 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 3/3/2022 - 3 years ago
    5 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 3/3/2022 - 3 years ago
    4 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 3/3/2022 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/1/2021 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 6/16/2021 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP